Dr. Reddys Laboratories Ltd.

The revenue declined to Rs. 48387.00 millions for the quarter ended September 2023 as compared to Rs. 48803.00 millions during the corresponding quarter last year.The Company has registered profit of Rs. 11926.00  millions for the quarter ended September 2023, a growth of 6.84%  over Rs. 11163.00 millions millions achieved in the corresponding quarter of last year.A decline of 18522.00 millions was observed in the OP in the quarter ended September 2023 from 19208.00 millions on QoQ basis.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202309	202209	% Var	202309	202209	% Var	202303	202203	% Var
Sales	48387.00	48803.00	-0.85	102760.00	85109.00	20.74	169625.00	144052.00	17.75
Other Income	2231.00	1180.00	89.07	4567.00	5214.00	-12.41	5913.00	4820.00	22.68
PBIDT	18522.00	19208.00	-3.57	43135.00	29037.00	48.55	48061.00	30761.00	56.24
Interest	58.00	17.00	241.18	103.00	115.00	-10.43	169.00	380.00	-55.53
PBDT	18464.00	19191.00	-3.79	43032.00	28922.00	48.79	47892.00	30381.00	57.64
Depreciation	2458.00	2262.00	8.66	4830.00	4477.00	7.88	9232.00	8143.00	13.37
PBT	16006.00	16929.00	-5.45	38202.00	24445.00	56.28	38660.00	22238.00	73.85
TAX	4080.00	5766.00	-29.24	9882.00	8287.00	19.25	12532.00	6006.00	108.66
Deferred Tax	120.00	2790.00	-95.70	535.00	3953.00	-86.47	3891.00	2080.00	87.07
PAT	11926.00	11163.00	6.84	28320.00	16158.00	75.27	26128.00	16232.00	60.97
Equity	834.00	832.00	0.24	834.00	832.00	0.24	833.00	832.00	0.12
PBIDTM(%)	38.28	39.36	-2.74	41.98	34.12	23.04	28.33	21.35	32.69